Clinical myocardial perfusion PET/CT

240Citations
Citations of this article
215Readers
Mendeley users who have this article in their library.

Abstract

The field of nuclear cardiology is witnessing growing interest in the use of cardiac PET for the evaluation of patients with coronary artery disease (CAD). The available evidence suggests that myocardial perfusion PET provides an accurate means for diagnosing obstructive CAD, which appears superior to SPECT especially in the obese and in those undergoing pharmacologic stress. The ability to record changes in left ventricular function from rest to peak stress and to quantify myocardial perfusion (in mL/min/g of tissue) provides an added advantage over SPECT for evaluating multivessel CAD. There is growing and consistent evidence that gated myocardial perfusion PET also provides clinically useful risk stratification. Although the introduction of hybrid PET/CT technology offers the exciting possibility of assessing the extent of anatomic CAD (CT coronary angiography) and its functional consequences (ischemic burden) in the same setting, there are technical challenges in the implementation of CT-based transmission imaging for attenuation correction. Nonetheless, this integrated platform for assessing anatomy and biology offers a great potential for translating advances in molecularly targeted imaging into humans. Copyright © 2007 by the Society of Nuclear Medicine, Inc.

Cite

CITATION STYLE

APA

Di Carli, M. F., Dorbala, S., Meserve, J., El Fakhri, G., Sitek, A., & Moore, S. C. (2007). Clinical myocardial perfusion PET/CT. Journal of Nuclear Medicine, 48(5), 783–793. https://doi.org/10.2967/jnumed.106.032789

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free